HMGB1 as a Potential Therapeutic Target for Neuropathic Pain
Neuropathic pain, which is intolerable and persistent, arises as a direct consequence of a lesion or disease affecting the somatosensory system and can be debilitating for the affected patients. Accumulating evidence from animal studies has revealed the potential molecular basis for neuropathic pain...
Saved in:
Main Authors: | Takehiko Maeda (Author), Masanobu Ozaki (Author), Yuka Kobayashi (Author), Norikazu Kiguchi (Author), Shiroh Kishioka (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2013-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pioglitazone Attenuates Tactile Allodynia and Thermal Hyperalgesia in Mice Subjected to Peripheral Nerve Injury
by: Takehiko Maeda, et al.
Published: (2008) -
Possible Involvement of Endogenous Opioid System Located Downstream of α7 Nicotinic Acetylcholine Receptor in Mice With Physical Dependence on Nicotine
by: Keiko Ueno, et al.
Published: (2014) -
Chemogenetic Regulation of CX3CR1-Expressing Microglia Using Gi-DREADD Exerts Sex-Dependent Anti-Allodynic Effects in Mouse Models of Neuropathic Pain
by: Fumihiro Saika, et al.
Published: (2020) -
Nicotine Effects and the Endogenous Opioid System
by: Shiroh Kishioka, et al.
Published: (2014) -
Activation of Spinal Cholecystokinin and Neurokinin-1 Receptors Is Associated With the Attenuation of Intrathecal Morphine Analgesia Following Electroacupuncture Stimulation in Rats
by: Yohji Fukazawa, et al.
Published: (2007)